Thursday, August 07, 2025 | 09:11 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Novelix Pharmaceuticals Share Price

Know More
BSENSE

₹42.20 1.95 (4.84%)

04:01 PM, 7-Aug-2025
Stock not traded

BSE : 536565

Sector : Health care

ISIN Code : INE314I01036

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 07-Aug-2025 | 10:31 AM IST

Market Cap (₹ Cr)

105

Traded Value (₹ Cr)

0.01

Volume (Shares)

1,314

Face Value (₹)

10

52-Week High (₹)

52.79

52-Week High Date

15-Jul-2025

52-Week Low (₹)

20.87

52-Week Low Date

12-Aug-2024

All Time High (₹)

74.60

All Time High Date

12-Jan-2010

All Time Low (₹)

1.85

All Time Low Date

03-Mar-2020

Novelix Pharmaceuticals Ltd

Trimurthi Limited was formerly incorporated on December 13 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs & Pharmaceuticals Ltd. In September 2006 as per the Scheme of Arrangement the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Com...
Read More
BSE

Novelix Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

105

EPS - TTM (₹) [C]

0.00

P/E Ratio (X) [C]

-

Face Value (₹) 10
Latest Dividend (%)3.00
Latest Dividend Date 16-Aug-2012
Dividend Yield (%) -
Book Value Share (₹) [C]15.65
P/B Ratio (₹) [C]2.70

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Data Not Found

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

38.25

42.26

Week Low/High (₹)

38.25

46.00

Month Low/High (₹)

38.25

53.00

Year Low/High (₹)

20.87

53.00

All time Low/High (₹)

1.85

75.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-1.86%--0.69%-0.70%
1 Month0.05%--3.38%-3.40%
3 Month---0.15%0.74%
6 Month--3.55%4.40%
1 Year--1.45%1.23%
3 Year--38.29%41.50%

Company Info

Company Information

Independent Director : Monam Kapoor

Independent Director : Janardhan Das Kabra

Whole-time Director : Venkateshwarlu Pulluru

Company Sec. & Compli. Officer : Nishita Kalantri

Non Executive Director : Jivamohan Divakar Valluri

Non Executive Director : Lakshman Samala

Registered Office: 4-4-231/1/2/ABC Inderbagh, Sultan Bazar,Hyderabad,Telangana-500095 Ph: 91-40-24757370

Email:info@trimurthidrugs.com

URL:http://www.trimurthidrugs.com

FAQs about Novelix Pharmaceuticals Ltd

1. What's the Novelix Pharmaceuticals Ltd share price today?
Novelix Pharmaceuticals Ltd share price was Rs 42.20 at 04:01 PM IST on 7th Aug 2025. Novelix Pharmaceuticals Ltd share price was up by 4.84% over the previous closing price of Rs 40.25. Novelix Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Novelix Pharmaceuticals Ltd share price moved up by 0.05% on BSE.


2. How can I quickly analyse the performance of the Novelix Pharmaceuticals Ltd stock?
The performance of the Novelix Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • Price to book value ratio is 2.70


3. What is the market cap of Novelix Pharmaceuticals Ltd?
Novelix Pharmaceuticals Ltd has a market capitalisation of Rs 105 crore.


4. What is Novelix Pharmaceuticals Ltd's 52-week high/low share price?
The Novelix Pharmaceuticals Ltd’s 52-week high share price is Rs 52.79 and 52-week low share price is Rs 20.87.


5. Is the Novelix Pharmaceuticals Ltd profitable?
On a consolidated basis, Novelix Pharmaceuticals Ltd reported a loss of Rs -0.15 crore on a total income of Rs 1.30 crore for the quarter ended 2022. For the year ended 2022, Novelix Pharmaceuticals Ltd had posted a loss of Rs -2.03 crore on a total income of Rs 8.91 crore.


6. Which are Novelix Pharmaceuticals Ltd’s peers in the Health care sector?
Novelix Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Lactose (India), Rajnish Wellness, Amwill Health, Novelix Pharma., Achyut Healthcar, Samrat Pharma, Asston Pharmaceu.


7. Who owns how much in Novelix Pharmaceuticals Ltd?
Key changes to the Novelix Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Novelix Pharmaceuticals Ltd has gone down to 52.75 per cent as of Jun 2025 from 66.56 per cent as of Dec 2024.